Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Winn

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Biology of Reproduction|June 1, 1995
Effects of relaxin administration in early gestation or prior to mating on uterine length and fetal survival in giltsH M Zaleski, R J Winn, R L Jennings, et al.
Cancer Practice|May 1, 1997
Terminally ill cancer patients. Their most important concernsA J Greisinger, R J Lorimor, L A Aday, et al.
Cancer Detection and Prevention|January 1, 1990
Breast screening compliance following a statewide low-cost mammography projectV G Vogel, D S Graves, D K Coody, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesotheliomaH M Dhingra, W K Murphy, R J Winn, et al.
Endocrinology|December 1, 1989
Hormonal control of the cervix in pregnant gilts. II. Relaxin promotes changes in the physical properties of the cervix in ovariectomized hormone-treated pregnant giltsM B O'Day, R J Winn, R A Easter, et al.
Oncology Nursing Forum|October 1, 1996
Barriers to cancer treatment: a review of published researchJ J Guidry, A Greisinger, L A Aday, et al.
Progress in Clinical and Biological Research|January 1, 1984
An evaluation of physician determinants in the referral of patients for cancer clinical trials in the community settingR J Winn, J Miransky, J F Kerner, et al.
Endocrinology|October 1, 1991
Hormonal control of the cervix in pregnant gilts. III. Relaxin's influence on cervical biochemical properties in ovariectomized hormone-treated pregnant giltsM B O'Day-Bowman, R J Winn, P J Dziuk, et al.
Controlled Clinical Trials|December 1, 1996
Participants' perceptions of a phase I colon cancer chemoprevention trialK S Hudmon, C Stoltzfus, R M Chamberlain, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Biology of Reproduction|June 1, 1995
Effects of relaxin administration in early gestation or prior to mating on uterine length and fetal survival in giltsH M Zaleski, R J Winn, R L Jennings, et al.
Cancer Practice|May 1, 1997
Terminally ill cancer patients. Their most important concernsA J Greisinger, R J Lorimor, L A Aday, et al.
Cancer Detection and Prevention|January 1, 1990
Breast screening compliance following a statewide low-cost mammography projectV G Vogel, D S Graves, D K Coody, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesotheliomaH M Dhingra, W K Murphy, R J Winn, et al.
Endocrinology|December 1, 1989
Hormonal control of the cervix in pregnant gilts. II. Relaxin promotes changes in the physical properties of the cervix in ovariectomized hormone-treated pregnant giltsM B O'Day, R J Winn, R A Easter, et al.
Oncology Nursing Forum|October 1, 1996
Barriers to cancer treatment: a review of published researchJ J Guidry, A Greisinger, L A Aday, et al.
Progress in Clinical and Biological Research|January 1, 1984
An evaluation of physician determinants in the referral of patients for cancer clinical trials in the community settingR J Winn, J Miransky, J F Kerner, et al.
Endocrinology|October 1, 1991
Hormonal control of the cervix in pregnant gilts. III. Relaxin's influence on cervical biochemical properties in ovariectomized hormone-treated pregnant giltsM B O'Day-Bowman, R J Winn, P J Dziuk, et al.
Controlled Clinical Trials|December 1, 1996
Participants' perceptions of a phase I colon cancer chemoprevention trialK S Hudmon, C Stoltzfus, R M Chamberlain, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinomaP M Hoff, J A Ellerton, S R Dakhil, et al.
Pageof 7